As of Aug 29
| -1.66 / -1.29%|
The 1 analysts offering 12-month price forecasts for Taro Pharmaceutical Industries Ltd have a median target of 190.00, with a high estimate of 190.00 and a low estimate of 190.00. The median estimate represents a +50.03% increase from the last price of 126.64.
The current consensus among 1 polled investment analysts is to Buy stock in Taro Pharmaceutical Industries Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.